- Presentations
- 7
- Markets
- 1
Gamifant is a brand of Emapalumab marketed by Swedish Orphan Biovitrum AB (publ), with 7 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Emapalumab
- Brand owner
- Swedish Orphan Biovitrum AB (publ)
- Registered in
- United States
- Strengths and forms
- 10 mg/2 mL injection, 100 mg/20 mL injection, 100 mg/4 mL injection, 250 mg/10 mL injection, 50 mg/10 mL injection, 50 mg/2 mL injection, 500 mg/20 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Gamifant 10 mg/2 mL injectionIntravenous Cold chain | Swedish Orphan Biovitrum AB (publ) | US FDA | Available on request |
| Gamifant 100 mg/20 mL injectionIntravenous Cold chain | Swedish Orphan Biovitrum AB (publ) | US FDA | Available on request |
| Gamifant 100 mg/4 mL injectionIntravenous Cold chain | Swedish Orphan Biovitrum AB (publ) | US FDA | Available on request |
| Gamifant 250 mg/10 mL injectionIntravenous Cold chain | Swedish Orphan Biovitrum AB (publ) | US FDA | Available on request |
| Gamifant 50 mg/10 mL injectionIntravenous Cold chain | Swedish Orphan Biovitrum AB (publ) | US FDA | Available on request |
| Gamifant 50 mg/2 mL injectionIntravenous Cold chain | Swedish Orphan Biovitrum AB (publ) | US FDA | Available on request |
| Gamifant 500 mg/20 mL injectionIntravenous Cold chain | Swedish Orphan Biovitrum AB (publ) | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Gamifant
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.